Merrill Lynch Greater Europe IT PLC
19 April 2005
MERRILL LYNCH GREATER EUROPE INVESTMENT TRUST plc
All information is at 31 March 2005 and unaudited.
Performance at month end with net income reinvested
One Three Since launch
Month Months (20Sep04)
Net asset value -1.3% 2.3% 13.9%
Share price -0.7% 6.9% 9.0%
FTSE World Europe ex UK -0.5% 1.5% 12.5%
Sources: Merrill Lynch Investment Managers and Datastream.
Net asset value and share price performance are both calculated using the issue
price of 100.00p. Share price performance was previously released with
reference to the first days closing share price of 94.00p.
At month end
Net asset value: 113.90p Includes net revenue of 0.15p
Share price: 109.00p
Discount to NAV: 4.3%
Gearing: 3.5%
Net yield: N/A
Total assets: £194.1m
Ordinary shares in issue: 164,841,285
Benchmark
Sector Analysis Total Assets (%) Index (%) Country Analysis Total Assets (%)
Financials 34.6 30.8 France 26.1
Cyclical Services 9.9 6.1 Germany 14.1
Resources 9.6 9.5 Switzerland 11.8
Non Cyclical Consumer Goods 8.1 15.0 Italy 10.3
Basic Industries 6.0 7.2 Scandinavia 8.1
Utilities 5.8 6.3 Sweden 5.2
Non Cyclical Services 5.7 1.4 Russia 3.1
Technology 5.5 4.8 Belgium 3.0
Telecoms 4.7 8.4 Ireland 2.9
Capital Goods 4.6 5.8 Spain 2.8
Cyclical Consumer Goods 3.4 4.7 Turkey 2.7
Other Investments 2.1 - Netherlands 2.6
Greece 2.1
Israel 2.1
Portugal 1.9
Other Countries 1.2
----- ----- -----
100.0 100.0 100.0
----- ----- -----
Ten Largest Equity Investments
Company % of Total Assets Country of Risk
UBS 4.0 Switzerland
Total 3.8 France
Sanofi-Aventis 3.1 France
Capitalia 2.9 Italy
AXA 2.6 France
Societe Generale 2.4 France
Carrefour 2.4 France
Roche Holdings 2.2 Switzerland
Belgacom 2.2 Belgium
Deutsche Boerse 2.0 Germany
----
Total 27.6
----
Commenting on the markets, James Macmillan, representing the Investment Manager
noted:
The start of 2005 saw a continuation of the strong economic growth momentum that
marked late 2004. However, this momentum came under pressure during March due
to higher energy prices, a pick up in inflation expectations and a rise in bond
yields, driven by fears that higher inflation would bring more aggressive
interest rate rises. During March the FTSE World Europe ex UK (net) declined by
0.5% in sterling terms and the MSCI Emerging Europe markets fell 8.3%.
The Company's NAV returned -1.3% during the month underperforming the reference
benchmark index.
Cyclical sectors performed well in March with Commercial Services & Supplies
(+3%), Hotels, Restaurants & Leisure (+3%) and Consumer Durable and Apparel
(+2%) outperforming the market. In addition some of the defensive sectors also
did well, these included Household & Personal Products advancing by 4% and Food
Beverages & Tobacco up 2%. Semiconductors (-5%) and Technology Hardware &
Equipment (-3%) were poor performers. Materials stocks (-3%) suffered profit
taking following a strong recent run.
During the period both stock and sector selection had a negative effect on
performance. From a portfolio perspective the Company benefited from its sector
exposure to Pharmaceuticals, Insurance and Energy. The worst contributing
sectors were Utilities, Retailing and Telecoms. The Company's exposure to
Emerging Europe, particularly Turkey, had a negative impact on performance, due
to investors taking profits given the strong performance of many shares in the
region so far this year.
During the period the best performing stocks were Italian financials Capitalia
(+4%) and Fondiaria (+4%), German sportswear manufacture PUMA (+9%) and French
retailer Carrefour (+3%). The main detractors were from a number of Greek and
Turkish holdings which included banks, Alpha Bank (-10%) and Emporiki Bank of
Greece (-17%), Akbank (-18%) and construction group Enka Insaat (-9%).
During March the Company purchased Sanofi-Aventis, Fortum and DNB Nor and made
significant additions to Deutsche Boerse and Publicis. These were funded by the
sale of ING Group, KBC, ASML and Unilever.
The main bias of the portfolio remains towards financials, mainly through banks
and insurance and more defensively orientated sectors such as energy, telecoms
and pharmaceuticals. The main country exposures are in France, Germany and
Switzerland. Our exposure to Emerging Europe decreased, finishing the month at
9.4%. The Company ended the month with a net market exposure of 103.5%.
The macroeconomic newsflow was mixed in March. Recent surveys suggest that
business confidence has deteriorated in Europe against a backdrop of a strong
Euro and high energy prices. However, earnings growth remains robust at close
to double-digit levels despite weak nominal revenue trends due to corporate
restructuring, both financial and operational. European equity valuations look
attractive on both an absolute and relative basis. Our outlook remains positive
on the Emerging Europe region, medium term, despite the pull back in March.
European stocks have so far been unaffected by the increases in U.S. interest
rates, however, there could be more inflation scares during the second quarter
and the key issue will be the trend in long bonds. We expect that European short
rates will stay low during 2005 as economic activity remains sluggish, across
most of the large Eurozone countries. However, if the global economy stays on
an expansionary trend, then it is not unreasonable to expect long-term interest
rates to increase modestly and this would be reflected in European interest
rates.
Latest information is available by typing www.mlim.co.uk/its on the internet,
'MLIMINDEX' on Reuters, 'MLIM' on Bloomberg or '8800' on Topic 3 (ICV terminal).
19 April 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.